Guidelines for Wound VAC Placement in Long-Term Care
Negative pressure wound therapy (NPWT/wound VAC) should be used selectively in long-term care settings—specifically for post-surgical wounds after debridement or minor amputation, but NOT for non-surgical chronic ulcers like pressure ulcers, diabetic foot ulcers, or venous ulcers. 1, 2
When to Place a Wound VAC
Appropriate Indications (Use NPWT)
- Post-surgical diabetic foot wounds after debridement or minor amputation when primary or delayed closure is not feasible 1
- Post-operative wounds following surgical debridement of infected tissue, abscess drainage, or necrotizing fasciitis 1
- Wounds after revascularization procedures that require staged closure 1
- Large wounds requiring preparation for skin grafting or two-stage primary closure 3
Contraindications (Do NOT Use NPWT)
- Non-surgical diabetic foot ulcers—this is a strong recommendation against use 1, 2
- Dry, non-exudative wounds—NPWT removes moisture and causes harm 2
- Pressure ulcers without surgical intervention—evidence shows no benefit over standard care 1
- Venous leg ulcers—insufficient evidence for benefit 4
- Wounds with inadequate perfusion (toe pressure <30 mmHg, TcPO2 <25 mmHg) until after revascularization 1, 5
Pre-Placement Requirements
Before considering wound VAC placement, ensure these conditions are met:
Vascular Assessment
- Measure ankle-brachial index (ABI), toe pressures, and transcutaneous oxygen pressure (TcPO2) 5
- Critical thresholds requiring revascularization FIRST: ABI <0.5, ankle pressure <50 mmHg, toe pressure <30 mmHg, or TcPO2 <25 mmHg 5
- Revascularization must precede or occur concurrently with NPWT—inadequate perfusion prevents healing regardless of wound VAC use 5
Infection Control
- Active infection must be resolved with surgical debridement and antibiotics before NPWT initiation 6
- Severe infections require IV antibiotics targeting MRSA and gram-negative bacteria 5
Surgical Debridement
- All nonviable tissue, necrotic material, and callus must be surgically removed before NPWT application 6, 3
- Sharp debridement is mandatory—NPWT is not a substitute for adequate surgical preparation 5
Application Protocol (When Indicated)
Technical Setup
- Apply sterile foam dressing to the debrided wound bed 7
- Embed fenestrated tubing in the foam 7
- Seal wound with adhesive tape to create airtight environment 7
- Set continuous or intermittent suction at 50-125 mmHg 7
Dressing Changes
- Change NPWT dressings every 48-72 hours (typically on 3rd day) 6, 7
- Perform serial sharp debridement at each dressing change 5
Expected Duration
- Average treatment duration is 8.2 weeks for lower extremity wounds 3
- Post-surgical diabetic foot wounds achieve satisfactory healing in approximately 22.8 days with NPWT versus 42.8 days with standard gauze 6
Alternative Standard Care (Preferred for Most Long-Term Care Wounds)
For non-surgical chronic wounds in long-term care, use this approach instead of NPWT:
For Pressure Ulcers
- Hydrocolloid or foam dressings to reduce wound size 1
- High-protein nutritional supplementation (30 energy percent protein) to prevent and heal pressure ulcers 1
- Appropriate support surfaces (air-fluidized beds superior to standard beds) 1
For Diabetic Foot Ulcers
- Hydrogels for dry wounds to maintain moisture and facilitate autolysis 2
- Total contact cast as gold standard offloading for plantar ulcers 2
- Sharp debridement at every visit to remove callus and nonviable tissue 2
- Consider hyperbaric oxygen therapy only after revascularization if standard care fails for 6 weeks 1, 2
For Wounds with Adequate Perfusion
- Optimize wound-healing environment: smoking cessation, glycemic control (HbA1c <7%), cardiovascular risk modification 1, 5
- Moisture-retentive dressings to maintain moist wound bed while controlling exudate 1
Critical Pitfalls to Avoid
- Never apply NPWT to non-surgical, dry wounds—this causes harm by removing essential moisture 2
- Never use NPWT as first-line therapy for chronic ulcers without surgical intervention 1
- Never apply NPWT before addressing inadequate perfusion—revascularization must come first 5
- Do not continue NPWT if wound has severe peripheral vascular disease (particularly forefoot/midfoot locations)—failure rate is high 3
- Avoid NPWT in frail elderly patients with multiple comorbidities unless post-surgical indication exists 1
Monitoring and Follow-Up
- Perform wound reassessment at least weekly to evaluate healing progress 5
- Monitor for systemic signs of infection: fever, tachycardia, spreading erythema 5
- If wound does not improve within 6 weeks despite optimal management, consider vascular imaging and revascularization 1
- Coordinate care through interdisciplinary team including vascular surgery, infectious disease, and wound care specialists 5